Preview Mode Links will not work in preview mode

Keeping Current

Nov 27, 2025

Are you up to date on emerging pharmacologic therapies transforming obesity and type 2 diabetes care?

Credit available for this activity expires: 11/28/26
Earn Credit / Learning Objectives & Disclosures:


Nov 25, 2025

Do you know whom to treat and why? Learn about identifying and treating at-risk metabolic dysfunction-associated steatohepatitis (MASH).

Credit available for this activity expires: 11/25/2026
Earn Credit / Learning Objectives & Disclosures:


Nov 24, 2025

Are you looking beyond the lung to provide holistic care for your patients with multimorbid chronic obstructive pulmonary disease (COPD)?

Credit available for this activity expires: 11/26/2025
Earn Credit / Learning Objectives & Disclosures:


Nov 24, 2025

Hear from our panel of obesity and diabetes experts about emerging obesity and type 2 diabetes therapies addressing cardiovascular, hepatic, and metabolic complications.

Credit available for this activity expires: 11/25/2026
Earn Credit / Learning Objectives & Disclosures:


Nov 20, 2025

Does the year 2025 mark a true, tangible shift toward biomarker-driven precision medicine for metastatic hormone-sensitive prostate cancer (mHSPC)?

Credit available for this activity expires: 11/18/26
Earn Credit / Learning Objectives & Disclosures: